Neuropathological and neuroradiological spectrum of pediatric malignant gliomas: correlation with outcome

Neurosurgery. 2011 Jul;69(1):215-24. doi: 10.1227/NEU.0b013e3182134340.

Abstract

Background: The diagnostic accuracy and reproducibility for glioma histological diagnosis are suboptimal.

Objective: To characterize radiological and histological features in pediatric malignant gliomas and to determine whether they had an impact on survival.

Methods: We retrospectively reviewed a series of 96 pediatric malignant gliomas. All histological samples were blindly and independently reviewed and classified according to World Health Organization 2007 and Sainte-Anne classifications. Radiological features were reviewed independently. Statistical analyses were performed to investigate the relationship between clinical, radiological, and histological features and survival.

Results: Cohort median age was 7.8 years; median follow-up was 4.8 years. Tumors involved cerebral hemispheres or basal ganglia in 82% of cases and brainstem in the remaining 18%. After histopathological review, low-grade gliomas and nonglial tumors were excluded (n = 27). The World Health Organization classification was not able to demonstrate differences between groups and patients survival. The Sainte-Anne classification identified a 3-year survival rate difference between the histological subgroups (oligodendroglioma A, oligodendroglioma B, malignant glioneuronal tumors, and glioblastomas; P = .02). The malignant glioneuronal tumor was the only glioma subtype with specific radiological features. Tumor location was significantly associated with 3-year survival rate (P = .005). Meningeal attachment was the only radiological criteria associated with longer survival (P = .02).

Conclusion: The Sainte-Anne classification was better able to distinguish pediatric malignant gliomas in terms of survival compared with the World Health Organization classification. In this series, neither of these 2 histological classifications provided a prognostic stratification of the patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Brain / diagnostic imaging*
  • Brain / metabolism
  • Brain / pathology*
  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / mortality
  • Brain Neoplasms / surgery
  • Child
  • Child, Preschool
  • Chromosomal Proteins, Non-Histone / metabolism
  • DNA-Binding Proteins / metabolism
  • Female
  • Glioma / diagnosis*
  • Glioma / mortality
  • Glioma / surgery
  • Humans
  • Infant
  • Infant, Newborn
  • Ki-67 Antigen / metabolism
  • Longitudinal Studies
  • Magnetic Resonance Imaging / methods
  • Male
  • Nerve Tissue Proteins / metabolism
  • Radiography
  • Regression Analysis
  • Reproducibility of Results
  • Retrospective Studies
  • SMARCB1 Protein
  • Survival Analysis
  • Transcription Factors / metabolism

Substances

  • Chromosomal Proteins, Non-Histone
  • DNA-Binding Proteins
  • Ki-67 Antigen
  • Nerve Tissue Proteins
  • SMARCB1 Protein
  • SMARCB1 protein, human
  • Transcription Factors